Application Server Market Shares, Strategies, And Forecasts, Worldwide, 2012 To 2018


WinterGreen Research announces that it has published a new study Mission Critical J2EE Application Server: Market Shares, Strategy, and Forecasts, Worldwide, 2012 to 2018. The 2012 study has 686 pages, 297 tables and figures. Worldwide Application Server markets are poised to achieve significant growth as Internet of things and the mobile Internet further evolve.
According to Susan Eustis, lead author of the study, "Significant investment in communications infrastructure will create demand for more sophisticated web development and web applications. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Application servers represent a significant aspect of Internet market evolution."

Application server mobile extensions are integrated in the Web apps development environments of vendors. Application server development can create Web applications using business server pages. They can use the mobile extensions of the Web application server, which makes the special requirements and characteristics of mobile devices available.

 
Application servers leverage evolving software delivery models, new development methodologies, emerging mobile application development, and open source software. Mobile application development projects targeting smartphones and tablets are an essential aspect of any departmental application initiative. Native PC projects are anticipated to give way to smartphone and tablet apps for the enterprise. Every enterprise has to have apps that give customers, distributors, partners, and suppliers access to information.
 
The smarter planet initiative elucidates the value of machine to machine transmission. Ubiquitous computing environments a microprocessor touches everything, information systems, agriculture, transportation, and hospitals. Things no one would recognize as computers have a processor: home appliances, cars, roads, clothes, even rivers and cornfields. . Electronic shopping, electronic trading, Internet banking, Internet brokers, music and video delivery, Internet auction and other systems have become widespread and taken for granted in the society, all leveraging computing components many of which feed information to application servers.
 
IBM is the dominant player in application server market, it sets a defacto industry standard for complex web offerings. IBM has achieved significant market advantage by positioning with a broad middleware product offering. IBM has been able to grow its market share steadily. The IBM WebSphere has robust functionality. It provides integration at every level of the IT systems.
 
IBM is able to leverage application servers, broker integration technology, business process management, mission critical messaging, and portals with a broad offering. Built in intelligence frequently leverages application servers that are used to create a web presence and manage the flow of information from sensors to systems.
 
Application servers are used to manage e-commerce and service interactions over the Web. Application servers support continuous, personalized web presence. The application server web capability represents expansion of earlier web based systems. New systems are more integrated. Systems vastly improve the reach of e-commerce sites. Analytics have been added. The aim of e-commerce is to achieve an expanding customer base, enhance customer retention, improve customer service, and achieve cross selling.
 
Manufacturers use application servers to improve the functioning of the supply chain. Service interactions are supported over the Web. Systems facilitate product design, inventory management, distribution, and shipment processes.
 
Application servers represent the core of cloud and the Web computing technologies. Efficient real time systems are critical to responding to demands imposed by implementing business process that is automated. The application server requirements are described below. Application server core technologies are failover, clustering, scalability, flexibility, and reliability.
 
Application servers leverage evolving software delivery models, new development methodologies, emerging mobile application development, and open source software. Mobile application development projects targeting smartphones and tablets are an essential aspect of any departmental application initiative. Native PC projects are anticipated to give way to smartphone and tablet apps for the enterprise. Every enterprise has to have apps that give customers, distributors, partners, and suppliers access to information.
 
The smarter planet initiative elucidates the value of machine to machine transmission. Ubiquitous computing environments a microprocessor touches everything, information systems, agriculture, transportation, and hospitals. Things no one would recognize as computers have a processor: home appliances, cars, roads, clothes, even rivers and cornfields. . Electronic shopping, electronic trading, Internet banking, Internet brokers, music and video delivery, Internet auction and other systems have become widespread and taken for granted in the society, all leveraging computing components many of which feed information to application servers.
 
IBM is the dominant player in application server market, it sets a defacto industry standard for complex web offerings. IBM has achieved significant market advantage by positioning with a broad middleware product offering. IBM has been able to grow its market share steadily. The IBM WebSphere has robust functionality. It provides integration at every level of the IT systems.
 
IBM is able to leverage application servers, broker integration technology, business process management, mission critical messaging, and portals with a broad offering. Built in intelligence frequently leverages application servers that are used to create a web presence and manage the flow of information from sensors to systems.
 
Application servers are used to manage e-commerce and service interactions over the Web. Application servers support continuous, personalized web presence. The application server web capability represents expansion of earlier web based systems. New systems are more integrated. Systems vastly improve the reach of e-commerce sites. Analytics have been added. The aim of e-commerce is to achieve an expanding customer base, enhance customer retention, improve customer service, and achieve cross selling.
 
Manufacturers use application servers to improve the functioning of the supply chain. Service interactions are supported over the Web. Systems facilitate product design, inventory management, distribution, and shipment processes.
 
Application servers represent the core of cloud and the Web computing technologies. Efficient real time systems are critical to responding to demands imposed by implementing business process that is automated. The application server requirements are described below. Application server core technologies are failover, clustering, scalability, flexibility, and reliability.
 
Companies Profiled
 
Market Leaders
  • IBM 
  • RedHat 
  • Microsoft 
  • Adobe Systems
  • Oracle
  • Attachmate / Novell
  • NEC
  • Fujitsu
Market Participants
  • Hewlett Packard
  • Progress Software
  • RedHat
  • SAP
  • Software AG
  • Tibco
  • Compuware
  • Workday
  • Apache
  • Cisco
  • HostBridge Technology
  • VMware
  • EMC
  • Fiorano
  • PolarLake
Browse Report With TOC : http://www.businessresearchindustry.com/report/application-server-market-shares-strategies-and-forecasts-worldwide-2012-to-2018.htm

» Read More...

Global And Italy PV Inverter Market 2013 Deep Research Report


2013 Deep Research Report on Global and Italy PV Inverter Industry was a professional and depth research report on Global and Italy PV Inverter Industry.

Firstly the report describes the background knowledge of PV Inverter, including PV Inverter(Grid On Grid Off >100Kw or <100Kw) Concepts Classification production process technical parameters; then statistics Global and Italy 44 Manufacturers PV Inverter product 2009-2016 Capacity production cost price production value Gross margins and other relevant data, statistics these enterprises PV Inverter  products, customers, raw materials, company background information, then summary statistics and analysis the relevant data of these enterprises. and get Global and Italy PV Inverter  2009-2016 production market share, different type PV Inverter production market share, Global and Italy PV Inverter demand supply and shortage, Global and Italy PV Inverter 2009-2016 production price cost Gross production value gross margins, etc. At the same time, the report analyzed and discussed supply and demand changes in PV Inverter market and business development strategies, conduct a comprehensive analysis on Global and Italy PV Inverter industry trends.


Finally, the report also introduced 500MW/year PV Inverter project Feasibility analysis and related research conclusions. In a word, It was a depth research report on Global and Italy PV Inverter industry. And thanks to the support and assistance from PV Inverter industry chain related experts and enterprises during Research Team survey and interviews.
Table of Contents
 
Chapter One PV Inverter Industry Overview 1
1.1 PV Inverter Definition 1
1.2 PV Inverter Product Specification 1
1.3 PV Inverter Price Analysis 2
1.4 PV Inverter Manufacturing Process 2
1.5 PV Inverter Cost Structure 5
1.6 PV Inverter Industry Overview 6

Chapter Second PV Inverter Industry Chain Analysis 6
2.1 PV Inverter Components Market Analysis 6
2.2 PV System Market Analysis 7
2.3 Component-PV Inverter-System Industry Chain Analysis 8

Chapter Three PV Inverter Productions Supply Sales Demand Market Status and Forecast 14 9
3.1 PV Inverter Productions Overview 14 9
3.2 Small Power (?10KW) Middle Power(10-100KW) Large Power(>100KW) PV Inverter Production Market Share 23 20
3.3 Grid On Grid Off PV Inverter Production Market Share 24 21
3.4 PV Inverter Demand 25 21
3.5 PV Inverter Supply Demand and Shortage 25 22
3.6 PV Inverter Cost Price Production Value Profit Margin 26 23

Chapter Four PV Inverter Key Manufacturer 27 24
4.1 SMA (Germany) 24
4.2 Power-One (USA) 38
4.3 KACO (Germany) 44
4.4 Fronius (Australia) 51
4.5 Siemens (Germany) 58
4.6 Satcon (USA) 61
4.7 Advanced Energy (USA) 66
4.8 Schneider (France) 73
4.9 Ingeteam (Spain) 78
4.10 AROS Solar (Italy) 81
4.11 Delta Energy (Germany) 88
4.12 Enphase (USA) 92
4.13 DB POWER (India) 97
4.14 KOSTAL (Germany) 100
4.15 DANFOSS (Denmark) 104
4.16 STECA (Germany) 107
4.17 GREEN POWER (Spain) 110
4.18 GAMESA (Spain) 114
4.19 HELIOS SYSTEMS (Spain) 117
4.20 SILIKEN ELECTRONICS (Spain) 124
4.21 LTI REENERGY (Germany) 129
4.22 JEMA ENERGY  (Spain) 132
4.23 ECLIPSE  (Italy) 135
4.24 SUNWAYS (Germany) 138
4.25 E-VILLAGE (Germany) 141
4.26 OUTBACK POWER  (USA) 145
4.27 AMMINI SOLAR  (India) 148
4.28 APOLLO SOLAR (USA) 151
4.29 SOLUTRONIC (Germany) 154
4.30 SOLAR-FABRIK (Germany) 159
4.31 EEI (Italy) 161
4.32 Santerno (Italy) 162
4.33 ELPOWER (Italy) 163
4.34 Fimer S.p.A. (Italy) 164
4.35 G-Tec Europe srl (Italy) 165
4.36 GEFRAN (Italy) 166
4.37 SIEL S.p.A. (Italy) 167
4.38 Italcoel Srl (Italy) 168
4.39 Layer Electronics S.r.l. (Italy) 169
4.40 LEF srl (Italy) 170
4.41 Answer Drives S.r.l. (Italy) 171
4.42 Astrid Energy Enterprises Spa (Italy) 172
4.43 Bonfiglioli Riduttori S.P.A. (Italy) 173
4.44 Carlo Gavazzi Automation SpA (Italy) 174

Chapter Five Downstream Application Analysis 140 175
5.1 Italy PV Inverter Demand Analysis 140 175
5.2 International Market PV Inverter Demand Analysis 142 176

Chapter Six China PV Inverter Project Investment Feasibility Analysis 177
6.1 PV Inverter Project Opportunities and Risks Analysis 177
6.2 PV Inverter Cost Analysis 178
6.3 500MW PV Inverter Project Feasibility Analysis 180
6.3.1 Project Overview 180
6.3.2 Buildings 180
6.3.3 Equipments 180
6.3.4 Feasibility Analysis 182

Chapter Seven PV Inverter Research Conclusions 183

» Read More...

Global And China Stainless Steel Kitchenware Industry 2013 Deep Research Report



2013 Deep Research Report on Global and China Stainless Steel Kitchenware Industry was a professional and depth research report on Global and China Stainless Steel Kitchenware Industry.

.
Firstly the report describes the background knowledge of Stainless Steel Kitchenware, including Stainless Steel Kitchenware (Pot Tableware Kitchen utensils) Concepts Classification production process technical parameters; then statistics Global and China 14 Manufacturers Stainless Steel Kitchenware product 2009-2013 Capacity production cost price production value Gross margins and other relevant data, statistics these enterprises Stainless Steel Kitchenware products, customers, raw materials, company background information, then summary statistics and analysis the relevant data of these enterprises. 

and get Global and China Stainless Steel Kitchenware 2009-2013 production market share, different Type Stainless Steel Kitchenware production market share, Global and China Stainless Steel Kitchenware demand supply and shortage, Global and China Stainless Steel Kitchenware 2009-2013 production price cost Gross production value gross margins, etc. At the same time, the report analyzed and discussed supply and demand changes in Stainless Steel Kitchenware market and business development strategies, conduct a comprehensive analysis on Global and China Stainless Steel Kitchenware industry trends. Finally, the report also introduced 5.5 million pieces/year Stainless Steel Kitchenware project Feasibility analysis and related research conclusions.

In a word, It was a depth research report on Global and China Stainless Steel Kitchenware industry. And thanks to the support and assistance from Stainless Steel Kitchenware industry chain related experts and enterprises during Research Team survey and interviews.
.
Table of Contents
 .
Chapter One Stainless Steel Kitchenware Industry Overview 1
1.1 Stainless Steel Kitchenware Definition 1
1.2 Stainless Steel Kitchenware Classification and Application 2
1.3 Stainless Steel Kitchenware Industry Chain Structure 3
1.4 Stainless Steel Kitchenware Industry Overview 3
1.4.1 Stainless Steel Kitchenware Association Between Stainless steel Cookware Industry and Upstream Industry 4
1.4.2 Stainless Steel Kitchenware Association Between Stainless steel Cookware Industry and downstream Industry 5

Chapter Two Stainless Steel Kitchenware International and China Market Analysis 6
2.1 International Market Analysis 6
2.1.1 Industry International Market Analysis 6
2.1.2 Stainless Steel Kitchenware Product and Technology dynamic 8
2.1.3 Stainless Steel Kitchenware Competitive Landscape Analysis 10
2.1.4 Stainless Steel Kitchenware International Key Countries Development Status 11
2.1.5 Stainless Steel Kitchenware International Market Development Trend 14
2.2 Stainless Steel Kitchenware China Market Analysis 15
2.2.1 Stainless Steel Kitchenware China Market Development History 15
2.2.2 Stainless Steel Kitchenware Product and Technology Developments 18
2.2.3 Stainless Steel Kitchenware Competitive Landscape Analysis 22
2.2.4 Stainless Steel Kitchenware China Key Regions Development Status 23
2.2.5 Stainless Steel Kitchenware China Market Development Trend 24
2.3 Stainless Steel Kitchenware International and China Market Comparison Analysis 25

Chapter Three Stainless Steel Kitchenware Development Environmental Analysis 26
3.1 China Macroeconomic Environment Analysis 26
3.1.1 China GDP Analysis 26
3.1.2 China CPI Analysis 28
3.1.3 China PMI Analysis 30
3.2 European Economic Environmental Analysis and Impact 33
3.3 United States Economic Environmental Analysis and Impact 36
3.4 Japan Economic Environmental Analysis and Impact 39
3.5 Global Economic Environmental Analysis and Impact 40

Chapter Four Stainless Steel Kitchenware Development Policy and Plan 42
4.1 China Government Policy and Development Plan 42
4.2 Sub-Industry Policy Analysis 42
4.3 Local Policy and Development Analysis 44
4.4 Downstream Industry Policy and Demand Analysis 44
4.5 Hotspots and Influence Analysis 46

Chapter Five Stainless Steel Kitchenware technological process and cost structure 48
5.1 Stainless Steel Kitchenware product technical parameters 48
5.2 Stainless Steel Kitchenware Technical Analysis 50
5.3 Stainless Steel Kitchenware Cost Structure 53

Chapter Six 2009-2013 Stainless Steel Kitchenware Productions Supply Sales Demand Market Status and Forecast  55
6.1 2009-2013 Stainless Steel Kitchenware Capacity Production Overview 55
6.2 2009-2013 Stainless Steel Kitchenware Production Market Share Analysis 62
6.3 2009-2013 Stainless Steel Kitchenware Sub-Industry Market Share Analysis 64
6.4 2009-2013 Stainless Steel Kitchenware Demand Overview  67
6.5 2009-2013 Stainless Steel Kitchenware Supply Demand and Shortage 67
6.6 2009-2013 Stainless Steel Kitchenware Import Export Consumption 68
6.7 2009-2013 Stainless Steel Kitchenware Cost Price Production Value Gross Margin 69

Chapter Seven Stainless Steel Kitchenware Key Manufacturers Analysis 70
7.1 ZWILLING 70
7.2 FISSLER 75
7.3 SEB 79
7.4 WMF 83
7.5 CALPHALON 87
7.6 THERMOS 101
7.7 SUPOR 105
7.8 ASD 109
7.9 Linkfair 113
7.10 ROBAM 117
7.11 GuanHua 120
7.12 AXA International Limited 124
7.13 HOMICHEF 127
7.14 MEYER 131

Chapter Eight Upstream Raw Materials Price Analysis and Influence 135
8.1 Upstream Raw Materials Price Analysis and Influence 135
8.2 Upstream Equipments Market Analysis and Influence 137
8.3 Down Stream Demand Analysis and Influence 140
8.4 Alternative Products Analysis and Influence 141

Chapter Nine Stainless Steel Kitchenware Marketing Channels Analysis 141
9.1 Stainless Steel Kitchenware Marketing Channels Status 141
9.2 Stainless Steel Kitchenware Marketing Channels Management 146
9.3 Stainless Steel Kitchenware Marketing Channels Establishment 149
9.4 Stainless Steel Kitchenware Marketing Channels Development Trend 150

Chapter Ten Stainless Steel Kitchenware Industry Development Trend 152
10.1 2012-2016 Stainless Steel Kitchenware Development Trend 194 152
10.2 2012-2016 Market Potential Forecast 157
10.3 2012-2016 R&D Trend 160
10.4 2012-2016 Marketing Channels Change Trend 162
10.5 2012-2016 Competition Pattern Development Trends 166
10.6 2012-2016 Import Export Development Trend 168

Chapter Eleven Stainless Steel Kitchenware Industry Development Proposals 169
11.1 Macroeconomic Development Countermeasures 169
11.2 New Firms Enter Market Strategy 171
11.3 New Project Investment Proposals 173
11.4 Marketing Channel Strategy Proposals 175
11.5 Competitive Environment Strategy Proposals 176

Chapter Twelve Stainless Steel Kitchenware New Project Investment Feasibility Analysis 178
12.1 Stainless Steel Kitchenware Project SWOT Analysis 178
12.2 Stainless Steel Kitchenware New Project Investment Feasibility Analysis 178

Chapter Thirteen Stainless Steel Kitchenware Industry Research Conclusions 181

Browse :

» Read More...

Construction Equipment Market - Global And China Forecast, Market Share, Size, Growth And Industry Analysis, 2011 - 2017


The construction equipment market is driven by factors such as growth in construction and mining activities, emergence of lease-based equipment, and increasing government investment in infrastructure development especially in developing nations.In addition demand by companies in infrastructure and real estateis also supporting the growth of the construction equipment market.

Browse Report : http://www.transparencymarketresearch.com/construction-equipment-market.html

This report titled “Construction Equipment Market – Global and China Forecast, Market Share, Size, Growth and Industry Analysis, 2011 – 2017,” provides in depth analysis, market size estimates, market shares and forecast for the period 2011– 2017 for the construction equipment market across the globe. The report analyzes four regional markets, namely the U.S., Europe, Asia and RoW, with special focus on China,forconstruction equipment,based on product types.

The global construction equipment market is expected to reach USD 192.3 billion by 2017 from USD 143.6billion in 2012, growing at a CAGR of 6.0% from 2012 to 2017.The earth-moving equipment segment is in a commanding position contributing about 43% to the total construction equipment market revenue in 2012. China accounted for majority of the global construction equipment consumption, with Europe at a distant second.

The construction equipment market is driven by factors such as growth in construction activities, emergence of lease-based equipment, and increasing government investment in infrastructure development especially in developing nations. In addition demand by companies in infrastructure and real estate is also supporting the growth of the construction equipment market.

Despite the encouragement by governments across the globe, there are certain factors inhibiting the growth of the construction equipment market such as uncertain economic conditions, and strict emission regulations. The increasing price of raw materials such as steel is also a major challenge for the construction equipment market.

Browse: http://www.transparencymarketresearch.com/construction-equipment-market.html

Asia is considered the most promising market for construction equipment worldwide due to relatively good performance of construction and mining industries, in countries like India and China. Europe holds the second largest share of the construction equipment market. China is the major contributor to the global construction equipment market and accounts for about 41.2% of the overall global sales of construction equipment. The construction equipment market in China in 2012 is estimated at USD 59.2 billion and is expected to reach USD 95.6 billion in 2017 at CAGR of 10.1% from 2012 to 2017. In addition, China also holds about 17% market share of the global agriculture equipment industry.

Some of the key players dominating the construction equipment market are Caterpillar (U.S.), Komatsu (Japan), Volvo (Sweden), Hitachi (Japan), Liebherr (Switzerland), Sany (China), Zoomlion (China), Terex (U.S.), Doosan (South Korea) and John Deere (U.S.). Caterpillar is the leading player in the global construction equipment industry. Some of the Chinese construction equipment market players dominating the global market are: Sany, Zoomlion, XCMG, Guangxi Liugong, Lonking and others.

This report titled “Construction Equipment Market – Global and China Forecast, Market Share, Size, Growth and Industry Analysis, 2011 – 2017,” provides in depth analysis, market size estimates, market shares and forecast for the period 2011- 2017 for the construction equipment market across the globe. The report analyzes four regional markets, namely China, the U.S. Europe and Asia for construction equipment based on product types.

Browse Source : http://www.transparencymarketresearch.com/construction-equipment-market.html

» Read More...

Circulating Tumor Cells Market (CTCs) And Cancer Stem Cells (CSCs) Market Report 2013


This is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSCmarkets as they are evolving.  In this report, we focus upon technical and business trends in these spaces as they are fast evolving.  

CTCs have been shown to have prognostic value in a number of cancer types and therefore there is extensive research and development activity to develop methodologies for CTC enumeration as well as analysis.  Furthermore, there is a lot of clinical trial activity in a number of different cancer classes seeking to establish the clinical utility of CTC measurements in various cancer subtypes.


Select Biosciences has performed worldwide market tracking wherein we’ve analyzed research trends in the study of CTCs and CSCs.  Qualitative and quantitative analysis of product vendors and their market penetrance, markers utilized for the capture/study of CTCs and CSCs as well as cancer classes wherein there is current research activity vis-à-vis CTCs and CSCs are described in this dataset derived from worldwide pools of researchers in November and December 2012—therefore these data reflect the current market landscape

Select Biosciences has also performed extensive analysis of the various clinical trials where CTCs are being enumerated and analyzed.  These clinical data set the trajectory of the clinical utility of CTCs

This data-driven characterization of the CTCs and CSCslandscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in Microsoft PowerPoint format.
Extensive Technical andMarket Analyses
Presented in this Report

Molecular Characterization of CTCs and CSCs

Technologies for Studying CTCs
  • CTC Analysis Workflow
  • Enrichment and Analysis Methodologies
  • Details of Selected Approaches for CTC Enumeration and Analysis
  • Name of Company/Institution
  • Microfluidics-based Approaches
  • Imaging-based Approaches
CTC and CSC Research Market Landscape
  • Bottom-up Market Survey Data: Qualitative and Quantitative Market Analysis
  • Product Vendors and their Penetrance into the Research Market
  • Methodologies for Studying CTCs and CSCs
  • Markers for Characterizing CTCs and CSCs
Downstream Analyses on Captured CTCs

CTC Quantitative Market Metrics
  • Revenues from Clinical Utilization—Market Size, Market Forecast, Growth Rate

Analysis of Clinical Utility of CTCs
  • Evidence for Biomarker Utility of CTCs
  • CTC and CSC Clinical Trials Analysis

Table of Content

Chapter I. Molecular Characterization of CTCs and CSCs
Generation and In Vivo Role of CTCs
CTCs vs. DTCs
Historical Milestones in the CTCs Space
Potential Utility of CTC Detection and Analysis
EMT as a Driver of Metastasis
Interrelationship Between EMT, CTCs, and the Metastatic Cascade
Different Classes of EMT
EMT Signaling Pathways
CTC Characteristics: Morphological and Molecular
Molecular Targets for Detection of CTCs and DTCs
CTC Markers for RT-PCR
Biology of CSCs
Markers for CSCs
Sub-populations of CSCs
Colorectal CSCs and Markers Thereof

Chapter II. Technologies for Studying CTCs
CTC Analysis Workflow
Summary of Methodologies
Enrichment and Analysis Methodologies
Details of Selected Approaches for CTC Enumeration and Analysis
Name of Company/Institution
Relevant Technology Details
Microfluidics-based Approaches
Imaging-based Approaches

Chapter III. CTC and CSC Research Market Landscape
Bottom-up Market Survey Data: Qualitative and Quantitative Market Analysis
Product Vendors and their Penetrance into the Research Market
Methodologies for Studying CTCs and CSCs
Markers for Characterizing CTCs and CSCs
Pathway Analysis of CSCs
Cancer Classes Studied: Quantitative Segmentation by Percentage
Downstream Analyses on Captured CTCs
CTC Quantitative Market Metrics
Revenues from Clinical Utilization—Market Size, Market Forecast, Growth Rate
Market Trajectory

Chapter IV. Analysis of Clinical Utility of CTCs
Potential Utility of CTCs as Biomarkers
CTC Clinical Studies Analysis
Summary of CTC Clinical Studies with Associated Clinical Data
CTC- and CSC-Focused Clinical Trials Analysis

Appendix I.  Details of CTC-Focused Clinical Trials

Appendix II.Research Methodology

» Read More...

Innovation In The Prefilled Syringe Industry - Biologics And Autoinjection Devices Shaping Future R&D Trends


GBI Research, the leading business intelligence provider, has released its latest research, Innovation in the Prefilled Syringe Market Biologics and Autoinjection Devices Shaping Future R&D Trends, which provides insights into possible future avenues of R&D in the prefilled syringe market. This includes an overview of problems and possible solutions, as well as discussion of how the devices have developed to date to address problems with contamination, safety, fragility and ease of use.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
    
 
The market for prefilled syringes is being driven by the rise in popularity of autoinjection devices for the home-use market. As health authorities seek to reduce costs, facilitating patients in self-administering their medication is one major way of reducing the strain on resources for providers. Additionally, patients prefer this option as it does not require them to travel to hospital and can be accommodated in their own home.
 
Innovation is also being driven by safety. This area has seen increasing innovation in response to regulations and guidelines concerning needlestick injury. This is an area of rising concern as the number of logged needlestick injuries in healthcare workers is high and thought to be considerably under-reported. Measures to ensure healthcare provider safety have been put in place, and pharmaceutical companies are responding by improving the safety of their prefilled syringes in order to increase their appeal and gain market share. Safety devices have moved from active devices, which require activation by the user, to passive, which are automatically activated. The next steps are being made in integrating the safety device into the needle during manufacture.
 

The development of injectable biologic therapies is a major factor in the future prospects of prefilled syringes. Although oral biologics are something that companies are aiming for and there are some in development, many peptides are broken down too quickly in the stomach and are therefore not useful in treatment. The mainstay of biologic treatment is likely to remain injectable, whether intravenous, subcutaneous or intramuscular, for the foreseeable future. As such, companies need to overcome the limitations of prefilled syringes in order to provide convenient method of administration and win market share.
 
Scope
  • An overview of issues in the market.
  • Innovative solutions to these problems.
  • Future developments expected in the market by leading players
Reasons to buy
  • Understand how the prefilled syringe market has adapted to issues.
  • Predict which innovations are likely to be most successful in the future.
  • Gain an understanding of areas of unmet need in the market
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Figures 5

2 Innovation in Prefilled Syringes - Overview 6
2.1 Overview 6
 
3 Innovation in Prefilled Syringes - Introduction 7
3.1 What are Prefilled Syringes? 7
3.2 The Current Position of Prefilled Syringes in the Pharmaceutical Market 7
3.3 Factors Fueling Growth of Prefilled Syringes 7
3.4 Issues around the Use of Prefilled Syringes 8
3.5 Where Does Innovation Lie? 8
4 Innovation in Prefilled Syringes - Current Device Technologies and Associated Drivers and Barriers 9
4.1 Glass Syringes versus Plastic Syringes 9
4.1.1 Fragility 9
4.1.2 Dimensional Variability 9
4.1.3 Siliconization 9
4.1.4 Delamination 10
4.1.5 Tungsten Contamination 10
4.2 Autoinjection Devices 11
4.3 Safety Devices on Prefilled Syringes 11
4.4 Prefilled Diluent Syringes 12
4.5 Biologics Driving Innovation in Prefilled Syringes 12

5 Innovation in Prefilled Syringes - Formulation Considerations and Challenges for Pharmaceutical Companies 13
5.1 Drug Viscosity 13
5.2 Extractables and Leachables 13
5.3 Lyophilized Drugs versus Liquid-stable Formulations 14
6 Innovations in Prefilled Syringes - Overcoming Current Barriers and Trends in Development 15
6.1 Innovative Ways of Gaining Life Cycle Extensions for Existing Products 15
6.2 Plastic Syringes Offer Some Improvements over Traditional Glass Syringes 16
6.2.1 Polypropylene 16
6.2.2 Cyclo-olefin Polymers and Co-polymers 16
6.3 Extractables and Leachables 18
6.3.1 Glass Coatings - Reducing Silicone and Silicone Baking 18
6.3.2 Coated Stoppers 18
6.4 Safety Innovations 19
6.5 Integrated Needles - Advancements on the Luer Lock System 20
6.6 Filling Technologies and Removing the Air Bubble 20
6.7 Needle Length - Reducing Length can Increase Accuracy of Subcutaneous Injections 20
6.8 Manufacturing Advances - Sterilizing Syringes 21
6.8.1 Restricted Access Barrier Systems 21
6.8.2 Electron Beam Sterilization Tunnels 21
6.9 Automating and Streamlining the Manufacture of Prefilled Syringes 22
6.10 Manufacturing Flexibility and Integrated Systems 22
6.11 Testing of Prefilled Syringes 23
6.12 Customization of Prefilled Syringes 23
6.13 Self-injection Improvements 24
6.14 Patient-centric Focus for CMOs 24

7 Appendix 25
7.1 Market Definitions 25
7.2 Abbreviations 25
7.3 Bibliography 25
7.4 Research Methodology 26
7.4.1 Coverage 26
7.4.2 Secondary Research 27
7.4.3 Primary Research 27
7.4.4 Expert Panel Validation 27
7.5 Contact Us 28
7.6 Disclaimer 28
.

» Read More...

Generic Growth Strategies Market - Driven By Impending Patent Cliff, Declining R&D Productivity And Government Initiatives To Reduce Healthcare Costs


GBI Research, the leading business intelligence provider, has released its latest research, Generic Growth Strategies Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs. The report provides a comprehensive overview of the generic drugs market in the US, the top five countries in the European Union (EU, covering the UK, France, Germany, Spain and Italy) and Japan. 

The report focuses on the detailed analysis of major strategies implemented by the top 10 generic companies in the generic drugs market along with company portfolios and strategic analysis. The report gives detail on the current landscape and changes that have structured the generic drugs market. The report also contains an impact analysis of the regulatory landscape in the major geographies pertaining to the generic drugs market. The report also provides in-depth analysis of the unmet needs, drivers and barriers that affect the global generics market. 
     
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
 
The global generics market generated revenues of approximately $162 billion with a growth of 9.3% in 2011, representing about 19% of generic market share in the international pharmaceutical market. The generic pharmaceutical industry is significantly fragmented; the top 10 pharmaceutical companies accounted for 26% of global generics sales by value in 2011. The US has very high levels of generic utilization, with nearly 80% of prescriptions dispensed being generics. 
 
The pharmaceutical industry will experience major patent expiries during 20132020, of which 2014 to 2017 are expected to be peak years, with the loss of patents for drugs whose sales were worth more than $76 billion during 2011. By 2015, branded products with sales of up to $135 billion will go off-patent, giving generic pharmaceutical companies immense opportunities to capitalize on the market. Along with generic drugs, pharmaceutical companies will also have the opportunity to develop biosimilars, as biologics with 2011 sales of approximately $64 billion will go off-patent over the next five years.
 

Scope
  • Detailed study of generic growth strategies with special emphasis on strategies which help in combating intensive competition.
  • Analysis of the major strategies adopted by companies looking to expand geographical reach.
  • Analysis of the generic pharmaceutical market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan.
  • Key drivers and barriers that have a significant impact on the market.
  • Competitive benchmarking of leading companies. Key companies studied in this report are Teva, Sandoz, Mylan, Watson, Actavis, Hospira, Sanofi, Daiichi Sankyo, Aspen and STADA.
Reasons to buy
  • Build understanding of the key generic growth strategies in place and the trends in the market.
  • Align your product portfolio to the markets with high growth potential.
  • Develop market-entry and market expansion strategies by identifying the potential region and therapeutics market segments poised for strong growth.
  • Create a more tailored country strategy through the understanding of key drivers and barriers in the global generics market.
  • Optimize your R&D pipeline through the identification and understanding of the key strategy for your drug. 
  • Identify the key players best positioned to capitalize on their products through the effective management of their patented products.
  • Develop effective business strategies related to generic drugs through the analytical insight gained from case studies covering different strategies in the market.
Table of Contents

1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 10
1.2 List of Figures 10

2 Generic Growth Strategies - Introduction 11
3 Generic Growth Strategies - Market Overview 12
3.1 Overview of the Generics Market 12
3.1.1 Leading Generics Companies 12
3.1.2 Generics Market Share 14
3.2 Drivers and Restraints 15
3.2.1 Drivers 16
3.2.2 Restraints 21

4 Generic Growth Strategies - Regulatory Landscape 23
4.1 The US 23
4.1.1 Hatch-Waxman Act and ANDA 23
4.1.2 Shortening Market Exclusivity of Biopharmaceuticals and Impact on Generics 25
4.1.3 Pay-For-Delay Ban to be Detrimental to Innovators as Well as Generics 25
4.1.4 Cost-sharing of Generic Drugs 25
4.1.5 Impact of Supplemental Examination Provision of Patent Reform Act on Generics 26
4.1.6 Biologics Price Competition and Innovation Act Falls Short 26
4.2 Europe 28
4.2.1 Generic Penetration 28
4.2.2 Generic Substitution 29
4.2.3 Pricing and Reimbursement 29
4.2.4 Marketing Authorization for Generics 29
4.2.5 Generic Landscape in Leading European Markets 29
4.2.6 Common European Union Patent System 31
4.2.7 Tendering 32
4.2.8 Regulatory Landscape for Biosimilars 32
4.2.9 The Future of Biosimilars is Advancing Along a Path Smoothened by European Groundwork 32
4.3 Japan 33
4.3.1 Generics 33
4.3.2 Biosimilar 34

5 Generic Growth Strategies - Major Strategies 35
5.1 Authorized Generics 35
5.1.1 Case Study 37
5.2 Mergers and Acquisitions 37
5.2.1 Vertical Integration 39
5.2.2 Therapeutic Expansion - Biosimilars 39
5.3 Outsourcing 40
5.3.1 Outsourcing Opportunities in Biosimilars 40
5.3.2 Outsourcing is Also a Source of Income for Generics Companies 40
5.4 Marketing Partnership 41
5.4.1 Case Studies 41
5.5 Paragraph IV Certifications 42
5.5.1 Case Studies 42
5.5.2 Example of a Paragraph IV Challenge That Did Not Work Out for a Generic 42
5.6 R&D Strategies Employed by Key Players in the Generics Market 43
5.6.1 Super Generics 43
5.6.2 Biosimilars 44
5.7 Increasing Awareness and Acceptance 46

6 Generic Growth Strategies - Competitive Landscape 47
6.1 Teva Pharmaceutical Industries Limited 47
6.1.1 Overview 47
6.1.2 Revenue Analysis 47
6.1.3 Therapeutic Focus 48
6.1.4 Geographic Focus 48
6.1.5 Generic Growth Strategies 48
6.1.6 SWOT 51
6.2 Sandoz 52
6.2.1 Overview 52
6.2.2 Revenue Analysis 52
6.2.3 Therapeutic Focus 52
6.2.4 Geographic Focus 52
6.2.5 Generic Growth Strategies 53
6.2.6 SWOT 54
6.3 Mylan 55
6.3.1 Overview 55
6.3.2 Revenue Analysis 55
6.3.3 Therapeutic Focus 55
6.3.4 Geographic Focus 55
6.3.5 Generic Growth Strategies 57
6.3.6 SWOT 58
6.4 Watson 59
6.4.1 Overview 59
6.4.2 Revenue Analysis 59
6.4.3 Therapeutic Focus 59
6.4.4 Geographic Focus 59
6.4.5 Generic Growth Strategies 60
6.4.6 SWOT 61
6.5 Actavis 62
6.5.1 Overview 62
6.5.2 Revenue Analysis 62
6.5.3 Therapeutic Focus 62
6.5.4 Geographic Focus 62
6.5.5 Generic Growth Strategies 62
6.5.6 SWOT 63
6.6 Hospira 64
6.6.1 Overview 64
6.6.2 Revenue Analysis 64
6.6.3 Therapeutic Focus 64
6.6.4 Geographic Focus 64
6.6.5 Generic Growth Strategies 65
6.6.6 SWOT 66
6.7 Sanofi 67
6.7.1 Overview 67
6.7.2 Revenue Analysis 67
6.7.3 Geographic Focus 67
6.7.4 Generic Growth Strategies 67
6.7.5 SWOT 68
6.8 Daiichi Sankyo 68
6.8.1 Overview 68
6.8.2 Revenue Analysis 68
6.8.3 Geographic Focus 68
6.8.4 Generic Growth Strategies 68
6.8.5 SWOT 69
6.9 Aspen 69
6.9.1 Overview 69
6.9.2 Revenue Analysis 69
6.9.3 Geographic Focus 69
6.9.4 Generic Growth Strategies 70
6.9.5 SWOT 70
6.10 STADA 71
6.10.1 Overview 71
6.10.2 Revenue Analysis 71
6.10.3 Therapeutic Focus 71
6.10.4 Geographic Focus 71
6.10.5 Generic Growth Strategies 72
6.10.6 SWOT 72

7 Generic Growth Strategies - Conclusion 73
8 Generic Growth Strategies - Appendix 74
8.1 Market Definitions 74
8.2 Abbreviations 74
8.3 Bibliography 75
8.4 Research Methodology 77
8.4.1 Coverage 77
8.4.2 Secondary Research 77
8.4.3 Primary Research 78
8.4.4 Expert Panel Validation 78
8.5 Contact Us 78
8.6 Disclaimer 78
.

» Read More...

Stem Cell Therapy Market In Asia-Pacific To 2018 - Commercialization Supported By Favorable Government Policies, Strong Pipeline And Increased Licensing Activity


GBI Research, the leading business intelligence provider, has released its latest research Stem Cell Therapy Market in Asia-Pacific to 2018 Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity. The report provides an in-depth analysis on stem cell research and development in India, China, Japan, South-Korea and Singapore. The report market analysis and forecasts for CABG, LSCT, Type 1 DM, Type 2 DM, Hearticellgram, Cerecellgram, Cartistem and Cupistem. The report also provides information on trends and pipelines. In addition to this, the report covers market drivers and challenges for stem cell research market.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

    
 
GBI Research analysis finds the stem cell therapy market was valued at $545m in 2012, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10% from 2012 to 2018, to attain a value of $972m in 2018. The market is poised for significant growth in the forecast period due to the anticipated launch of JCR Pharmaceuticals JR-031 (2014) in Japan and FCB Pharmicells Cerecellgram (CCG) (2015) in South Korea. The research is mainly in early stages, with the majority of the molecules being in early stages of development (Phase I/II and Phase II). Phase I/II and Phase II contribute 67% of the pipeline. 

Stem cell research is dominated by hospitals/universities/institutions, which contribute 63% of the molecules in the pipeline. The dominance of institutional research is attributable to uncertain therapeutic outcomes in stem cell research.The major companies conducting research in India include Reliance Life Sciences and Stempeutics Research Pvt Ltd, among others. The major institutions include PGIMER and AIIMS.

 
Scope
  • Country analysis of regulatory framework of India, China, South-Korea, Japan and Singapore
  • In-depth information and analysis on the pipeline products expected to bring a shift to the market positions of the leading manufacturers. 
  • Market characterization data for stem cell research for CABG, LSCT, Type 1 DM, Type 2 DM, Hearticellgram, Cerecellgram, Cartistem and Cupistem. 
  • Key drivers and restraints that have a significant impact on the market.
  • Competitive landscape of stem cell research in Asia-Pacific. The key companies discussed in this report are Stempeutics, Reliance Lifesciences, International Stem cell services, Shenzhen Beike Biotechnology, JCR Pharmaceuticals, ES Cells International, Stem Cell Technologies i, Pharmicell and Medipost
  • Key M&A activities, licensing agreements, that have taken place between stem cell companies in 2007 till date.
Reasons to buy
  • Build effective strategies to launch pipeline products by identifying the latest regulatory developments in the leading geographies
  • Develop market-entry and market expansion strategies by identifying the geographic markets poised for strong growth 
  • Exploit in-licensing and out-licensing opportunities by identifying products that could fill their portfolio gaps 
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships
  • Develop key strategic initiatives by studying the key strategies of top competitors
  • Reinforce R&D pipelines by identifying licensing strategies for acquiring new delivery mechanisms that have more efficiency and better safety
Browse : Browse Report : Stem Cell Therapy Market 2018

Table of Contents
 
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 10


2 Stem Cell Therapy Market in Asia-Pacific to 2018 - Introduction 13

3 Stem Cell Therapy Market in Asia-Pacific to 2018 - Overview 14

3.1 Introduction 14
3.2 Market Characterization and Forecasts - Overview 15
3.2.1 Revenue Forecasts 15
3.2.2 Cost of Therapy 16
3.2.3 Allogeneic and Autologous Share 17
3.2.4 Stem Cell Therapy Patient Pool 18
3.3 Drivers and Barriers 19
3.3.1 Drivers 20
3.3.2 Barriers 20
4 Stem Cell Therapy Market in Asia-Pacific to 2018 - India 21
4.1 Introduction 21
4.2 Regulatory Landscape 21
4.3 Market Characterization and Forecasts - Overview 22
4.3.1 Revenue Forecasts 22
4.3.2 Cost of Therapy 23
4.3.3 Stem Cell Patient Pool 23
4.4 CABG Market Characterization and Forecasts 24
4.4.1 Introduction 24
4.4.2 Revenue Forecasts 24
4.4.3 Cost of Therapy 25
4.4.4 Stem Cell Patient Pool 26
4.5 Type 2 DM Market Characterization and Forecasts 27
4.5.1 Introduction 27
4.5.2 Revenue Forecasts 28
4.5.3 Cost of Therapy 29
4.5.4 Stem Cell Patient Pool 30
4.6 LSCT Market Characterization and Forecasts 31
4.6.1 Introduction 31
4.6.2 Revenue Forecasts 31
4.6.3 Cost of Therapy 32
4.6.4 Stem Cell Patient Pool 33

5 Stem Cell Therapy Market in Asia-Pacific to 2018 - China 34
5.1 Introduction 34
5.2 Regulatory Landscape 34
5.3 Market Characterization and Forecasts - Overview 35
5.3.1 Type 1 DM Market Characterization and Forecasts 35

6 Stem Cell Therapy Market in Asia-Pacific to 2018 - Japan 39
6.1 Introduction 39
6.2 Regulatory Landscape 39
6.3 Steroid Refractory aGvHD Market Characterization and Forecasts 41
6.3.1 Overview 41
6.3.2 Revenue Forecasts 42
6.3.3 Cost of Therapy 43
6.3.4 Stem Cell Patient Pool 44

7 Stem Cell Therapy Market in Asia-Pacific to 2018 - Singapore 45
7.1 Introduction 45
7.2 Regulatory Landscape 45
7.2.1 Ethical, Legal and Social Issues in Human Stem Cell Research, Reproductive and Therapeutic Cloning (June 2002) 46
7.2.2 Human Tissue Research (November 2002) 47
7.2.3 Research Involving Human Subjects (November 2004) 48
7.2.4 Genetic Testing and Genetic Research (November 2005) 49
7.2.5 Personal Information in Biomedical Research (May 2007) 50
7.2.6 Donation of Human Eggs for Research (November 2008) 50
7.2.7 Human-Animal Combinations in Stem Cell Research (September 2010) 50

8 Stem Cell Therapy Market in Asia-Pacific to 2018 - South Korea 51
8.1 Introduction 51
8.2 Regulatory Landscape 51
8.3 Market Characterization and Forecasts - Overview 53
8.3.1 Revenue Forecasts 53
8.3.2 Cost of Therapy 55
8.3.3 Stem Cell Patient Pool 56
8.4 Cupistem Market Characterization and Forecasts 57
8.4.1 Overview 57
8.4.2 Revenue Forecasts 58
8.4.3 Cost of Therapy 59
8.4.4 Stem Cell Patient Pool 60
8.5 HCG-AMI Market Characterization and Forecasts 61
8.5.1 Overview 61
8.5.2 Revenue Forecasts 62
8.5.3 Cost of Therapy 63
8.5.4 Stem Cell Patient Pool 64
8.6 Cartistem Market Characterization and Forecasts 65
8.6.1 Overview 65
8.6.2 Revenue Forecasts 66
8.6.3 Cost of Therapy 67
8.6.4 Stem Cell Patient Pool 68
8.7 CCG Market Characterization and Forecasts 69
8.7.1 Overview 69
8.7.2 Revenue Forecasts 69
8.7.3 Cost of Therapy 70
8.7.4 Stem Cell Patient Pool 71

9 Stem Cell Therapy Market in Asia-Pacific to 2018 - Pipeline Analysis 72
9.1 Pipeline Analysis by Phase 72
9.2 Pipeline Analysis by Sponsors/Collaborators 73
9.3 Pipeline Analysis by Country 74
9.3.1 India Stem Cell R&D Pipeline 75
9.3.2 China Stem Cell R&D Pipeline 77
9.3.3 Japan Stem Cell R&D Pipeline 81
9.3.4 Singapore Stem Cell R&D Pipeline 85
9.3.5 South Korea Stem Cell R&D Pipeline 86
9.3.6 Product Profiles of Promising Molecules 88
9.3.7 Product Profiles of Marketed Products 89

10 Stem Cell Therapy Market in Asia-Pacific to 2018 - Competitive Landscape 91
10.1 Stempeutics Research 91
10.1.1 Overview 91
10.1.2 Product Pipeline 92
10.2 Reliance Life Sciences 93
10.2.1 Overview 93
10.2.2 Product Pipeline 93
10.3 International Stem Cell Services 94
10.3.1 Overview 94
10.3.2 Product Pipeline 94
10.4 Shenzhen Beike Biotechnology 95
10.4.1 Overview 95
10.4.2 Product Pipeline 95
10.5 JCR Pharmaceuticals 96
10.5.1 Overview 96
10.5.2 Product Pipeline 96
10.6 ES Cells International (Subsidiary of BioTime, Inc) 97
10.6.1 Overview 97
10.6.2 Product Pipeline 97
10.7 Stem Cell Technologies i 98
10.7.1 Overview 98
10.7.2 Product Pipeline 98
10.8 Pharmicell 99
10.8.1 Overview 99
10.8.2 Product Pipeline 99
10.9 Medipost 100
10.9.1 Overview 100
10.9.2 Product Pipeline 100

11 Stem Cell Therapy Market in Asia-Pacific to 2018 - Strategic Consolidations 101
11.1 Overview 101
11.2 M&A Deals 102
11.2.1 RNL BIO Acquired 10% Stake in Celltex Therapeutics for $10m - October 28, 2011 102
11.2.2 BioTime Acquired ES Cell International - May 3, 2010 102
11.2.3 BCCL Acquires Stake in Life Cell - May 1, 2007 102
11.3 Licensing Deals 102
11.3.1 RNL BIO Forms Joint Venture to Develop Stem Cell Therapy - September 29, 2011 102
11.3.2 Kiadis Pharma Enters into Licensing Agreement with Hospira for ATIR - January 4, 2011 102
11.3.3 Cipla Enters into Co-Marketing Agreement with Stempeutics - April 27, 2010 102
11.3.4 Teijin Enters into Licensing Agreement with SanBio - March 2, 2010 102
11.3.5 Cleveland BioLabs Enters into Licensing Agreement with Zhejiang Hisun Pharma - September 9, 2009 103
11.3.6 Merck Signs a Licensing Agreement with Japan Tobacco - September 25, 2008 103
11.3.7 ES Cell Enters into Licensing Agreement with ITI Life Sciences - January 31, 2007 103
11.4 Co-Development Deals 103
11.4.1 JCR Pharma Enters into Co-Development Agreement with MediPal - September 13, 2011 103
11.4.2 Athersys Enters into Co-Development Agreement with Pfizer - December 21, 2009 103
11.4.3 Genzyme Enters into Agreement with Osiris Therapeutics - November 4, 2008 104
11.4.4 JCR Pharma Enters into Co-Development Agreement with Mochida Pharma - December 21, 2007 104

12 Stem Cell Therapy Market in Asia-Pacific to 2018 - Appendix 105
12.1 Market Definitions 105
12.2 Abbreviations 105
12.3 Bibliography 107
12.4 Research Methodology 108
12.4.1 Coverage 108
12.4.2 Secondary Research 108
12.4.3 Primary Research 109
12.5 Therapeutic Landscape 109
12.5.2 Market Size by Geography 111
12.6 Geographical Landscape 112
12.7 Pipeline Analysis 112
12.8 Competitive Landscape 112
12.8.1 Expert Panel Validation 112
12.9 Contact Us 112
12.10 Disclaimer 112
.

» Read More...

Search This Blog

Archives

Business Research Industry. Powered by Blogger.